Investigational Nasal Aerosol in Children with Perennial Allergic Rhinitis

- Female, Maleergic Rhinitis
- Completed

Study Title: Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Female, Maleergic Rhinitis (PAR)

Teva Identifier: BDP-AR-306

ClinicalTrials.gov Identifier: NCT01783548

Study Status: Completed

Trial Condition(s): Female, Maleergic Rhinitis

Interventions: Drug: BDP Nasal Aerosol | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child

Age Range: 4 Years to 11 Years

Trial Duration: 01/01/2013 - 10/01/2013

Phase: Phase 3

Study Type

Interventional